Malaria vaccine: Questions and answers on supply, price, and market shaping

Malaria is a preventable and curable life-threatening parasitic disease, and yet there are still an estimated 627,000 deaths a year, of which 77 per cent are children under five years of age. This questions and answers update on new malaria vaccines, provides general information on malaria vaccine supply, price, and the ongoing market shaping efforts. Following the prequalification of R21/Matrix-M vaccine by WHO, UNICEF anticipates the market will have sufficient malaria vaccine supply to meet all demand by 2024, and over time, it expects the weighted average price to fall.